pharma news

News

Bottle of Qulipta superimposed on image of woman holding head against sun dappled wall

AbbVie charts a new course for CGRPs in menstrual migraine

AbbVie's Qulipta has become the first oral CGRP inhibitor to show efficacy in a phase 3 study involving women with menstrual migraine.

News

UK review recommends 'L plates' for new healthcare AIs

A report has concluded that the current regulatory framework in the UK is inadequate for healthcare AI, and makes 44 recommendations to set it right.

News

Encoded raises $275m for Dravet therapy and other financings

Our round-up of biotech financings is headed by Encoded, which has raised $275m to advance its gene therapy for Dravet syndrome into pivotal trials.

News

Five indications added to Pharmacy First prescribing scheme

Some pharmacists in England can now prescribe drugs for acne, migraines, scabies, ear infections, and rhinitis under the Pharmacy First scheme.

News

Could UK clinical trial revamp unlock closer ties with Canad...

Two senior figures in Canada's life science sector have said they see scope for greater collaboration with the UK following clinical trial reforms.

News

Reviews underway of first drug for rare disease MOGAD

Patients with rare autoimmune disease MOGAD could be months away from having a first approved therapy, as the FDA starts a review of Roche's Enspryng.

AbbVie charts a new course for CGRPs in menstrual migraine

UK review recommends 'L plates' for new healthcare AIs

Encoded raises $275m for Dravet therapy and other financings

Five indications added to Pharmacy First prescribing scheme

Could UK clinical trial revamp unlock closer ties with Canad...

Reviews underway of first drug for rare disease MOGAD

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks